	Real-world second- and third-line progression-free survival after progression on first-line CDK4/6 inhibitors in HR+/HER2- metastatic breast cancer by PAM50 intrinsic subtype: the SOLTI-1801 CDK-PREDICT study. Breast Cancer Res Treat Tolosa P, García-Fructuoso I, Pascual T, Martínez-Sáez O, Cejalvo JM, Servitja S, Fernández Abad M, Benitez Fuentes JD, Brasó-Maristany F, Sanfeliu E, Lema L, Ruano Y, Parrilla L, Roncero AM, Cobos MÁ, Díaz I, Centelles López KA, Sánchez-Bayona R, Alva M, Madariaga A, Villacampa G, Salvador F, Sánchez-Belmonte A, Malumbres M, Prat A, Ciruelos E. PMID: 41762297 [PubMed - in process]
	Ovarian Cancer Imaging Strategies With Molecular Fluorescent Probes. Chemistry Fan N, Zu H, Li X, Zhou M, Li F, Li P, Li X. PMID: 41761917 [PubMed - as supplied by publisher]
	Targeting epigenetic networks to overcome cisplatin resistance in ovarian cancer: from mechanisms to clinical translation. J Ovarian Res Tang M, Wang Y, Xie Y, Li J, Ding D, Li C, Chen Q, Han F. PMID: 41761280 [PubMed - as supplied by publisher]
	Development and validation of an interpretable machine learning model for postoperative radiotherapy decision-making in ypN0 breast cancer after neoadjuvant chemotherapy: a real-world study. BMC Med Inform Decis Mak Zhang Y, Duan J, Hou N, Zhang X, Liang P, Chen X, Liu C, Wang Z, Ling R. PMID: 41761166 [PubMed - as supplied by publisher]
	Optimal Lossy Compression Scheme of 3D Volumetric Ultrasound Images For Remote Breast Cancer Screening. J Imaging Inform Med Huang Z, Huang J, Li X, Wang L, Yu H, Zhang Y, Song H, Gao Y. PMID: 41760971 [PubMed - as supplied by publisher]
	The landscape of the intestinal microbiome among patients with newly diagnosed invasive breast cancer and ductal carcinoma in situ (DCIS). NPJ Breast Cancer Sammons SL, Kuntz TM, DiLullo M, Morgan XC, Martin A, Hughes ME, Rahman T, Barroso-Sousa R, Ogayo ER, Giordano J, Ryan S, Waks AG, Schlam I, Ligibel J, Lin NU, Garrido-Castro AC, Mittendorf EA, Tolaney SM. PMID: 41760690 [PubMed - as supplied by publisher]
	Clinical impact of the methylation status of SMAD4 and AKR1B1 genes in a liquid biopsy sample as a prognostic marker for breast cancer. Sci Rep Swellam M, Ramadan A, Sobeih ME, Bakr NM. PMID: 41760667 [PubMed - as supplied by publisher]
	Reliability of Results from Randomized Studies and Systematic Reviews in Acupuncture: A Methodological Review for Acupuncture Against Symptoms of Breast Cancer Care. In Vivo Kreher KL, Dörfler J, Büntzel J, Büntzel J, Hübner J. PMID: 41760339 [PubMed - in process]
	Primary Debulking Surgery Versus Interval Debulking Surgery in the Management of Advanced-Stage Ovarian Cancer. Anticancer Res Micha JP, Bohart RD, Gorman JP, Goldstein BH. PMID: 41760235 [PubMed - in process]
	Artificial intelligence model for cardiovascular disease risk prediction in breast cancer patients using electronic health records and computed tomography scans. Radiother Oncol Shah I, Lucas S, Walsh R, Osman I, Shehata MS, Rajapakshe R. PMID: 41759965 [PubMed - as supplied by publisher]
	Ultra-hypofractionated whole breast irradiation and sequential tumor bed boost for early breast cancer (SHIFT): primary results of a multicentre, Phase 2 trial. Int J Radiat Oncol Biol Phys Zheng SY, Huang JQ, Xie JR, Gan L, Yu B, Shi YG, Jiang J, Zhang J, Dong ML, Qi WX, Cai G, Cai R, Xu C, Xu HP, Fang Qian X, Zhang YB, Cao L, Chen JY. PMID: 41759682 [PubMed - as supplied by publisher]
	The Extent of Indebtedness among Breast Cancer survivors in India: A Prospective Longitudinal Study from a Tertiary Cancer Hospital. J Cancer Policy Sen S, Mohanty SK, Wadasadawala T, Maiti S. PMID: 41759578 [PubMed - as supplied by publisher]
	A multimodal data-based model for breast cancer diagnosis. Comput Methods Programs Biomed Wang H, Wei L, Li J, Liu B, Fang J, Mooney C. PMID: 41759488 [PubMed - as supplied by publisher]
	Hierarchical contrastive disentanglement architecture for multi-modal breast cancer detection. Comput Biol Med Paliwal M, Kashyap KL. PMID: 41759454 [PubMed - as supplied by publisher]
	A Venous Thromboembolism-Associated Model for Predicting Tumor Microenvironment Features in Breast Cancer. Clin Breast Cancer Liu Z, Guo S, Xu X, Tang P, Xue H, Long X. PMID: 41759364 [PubMed - as supplied by publisher]
	Randomized trial of autologous ovarian graft to preserve ovarian function in young women undergoing pelvic radiotherapy for cervical cancer. Eur J Surg Oncol Bertolazzi M, Genta ML, Lopes A, Fernandes R, Maciel G, Lopez R, Baracat E, Carvalho J. PMID: 41759360 [PubMed - as supplied by publisher]
	Risk Stratified Breast Cancer Screening: Early Outcomes and Psychological Impact from PRSONAL - a Randomized Clinical Trial. Breast Pedersen LH, Bigaard J, Vejborg I, Kamstrup PR, Andersen B, Yang X, Ficorella L, Dennis J, Antoniou AC, Flyger H, Bojesen SE. PMID: 41759334 [PubMed - as supplied by publisher]
	Inhibiting CK2 in breast cancer: From molecular targets to drug candidates. Eur J Med Chem Al-Zoubi RM, Farhan A, Hanbali B, Al-Zoubi SR, Al-Qudimat AR, Al Zoubi MS, Khan A, Shkoor M, Al Jabiry A, Bani-Yaseen AD, Agouni A. PMID: 41759307 [PubMed - as supplied by publisher]
	Ferroptosis in ovarian cancer: Regulation, immunity, and therapeutic potential with the tumor microenvironment. Semin Oncol Jiang R, Yu Y, Guan J, Ma J, Qiu H, Zhong J, Liu N, Zhao H, Zheng Y, Du Y. PMID: 41759227 [PubMed - as supplied by publisher]
	Income Inequalities in Breast Cancer Survival Among Formally Employed Women in Colombia: A Cohort Study. JCO Glob Oncol Patiño-Benavidez AF, Ávila-Garzón LC, Sánchez-Santiesteban D, Mantilla W, Castillo JS, Muñoz V, Buitrago G. PMID: 41759057 [PubMed - in process]

Articles 1 - 20 / 325032

Page 1 of 16252



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy